0001178913-20-001359.txt : 20200507
0001178913-20-001359.hdr.sgml : 20200507
20200507203812
ACCESSION NUMBER: 0001178913-20-001359
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200507
FILED AS OF DATE: 20200507
DATE AS OF CHANGE: 20200507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harel Insurance Co LTD
CENTRAL INDEX KEY: 0001666482
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39279
FILM NUMBER: 20858381
BUSINESS ADDRESS:
STREET 1: ABBA HILLEL 3
CITY: RAMAT GAN
STATE: L3
ZIP: 5211802
BUSINESS PHONE: 97237547090
MAIL ADDRESS:
STREET 1: ABBA HILLEL 3
CITY: RAMAT GAN
STATE: L3
ZIP: 5211802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harel Insurance Investments & Financial Services Ltd.
CENTRAL INDEX KEY: 0001429390
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39279
FILM NUMBER: 20858382
BUSINESS ADDRESS:
STREET 1: HAREL HOUSE, 3 ABBA HILLEL ST.
CITY: RAMAT GAN
STATE: L3
ZIP: 52118
BUSINESS PHONE: 972-3-7547090
MAIL ADDRESS:
STREET 1: HAREL HOUSE, 3 ABBA HILLEL ST.
CITY: RAMAT GAN
STATE: L3
ZIP: 52118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001797336
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823578375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: (857) 444-0553
MAIL ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
3
1
ownership.xml
X0206
3
2020-05-07
0
0001797336
Ayala Pharmaceuticals, Inc.
AYLA
0001666482
Harel Insurance Co LTD
3 ABA HILLEL ROAD STREET
RAMAT GAN
L3
52118
ISRAEL
0
0
1
0
0001429390
Harel Insurance Investments & Financial Services Ltd.
3 ABA HILLEL ROAD STREET
RAMAT GAN
L3
52118
ISRAEL
0
0
1
0
Common Stock, par value $0.01 per share
1094385
I
See footnote
Series A Preferred Stock, par value $0.01 per share
Common Stock
307692
I
See footnote
Series B Preferred Stock, par value $0.01 per share
Common Stock
211757
I
See footnote
Share numbers in this Statement give effect to the reverse split of each share of the Issuer's Common Stock into 0.5 shares of Common Stock, which will be effective for the shares of Series A Preferred Stock and Series B Preferred Stock (together, the "Preferred Stock") upon their conversion into Common Stock upon the closing of the Issuer's initial public offering.
All of the shares of Common Stock and Preferred Stock reported in this Statement are directly held by Harel Insurance Company Ltd. ("Harel Insurance"), a wholly owned subsidiary of Harel Insurance Investments & Financial Services Ltd. ("Harel Holdings"), for Harel Insurance's own account. While Harel Insurance operates under independent management and makes independent voting and investment decisions, Harel Holdings may be deemed, by virtue of its ownership of Harel Insurance, to both beneficially own and have a pecuniary interest in all shares presently directly owned by Harel Insurance.
The Preferred Stock have no expiration date and are convertible at any time at the election of the holder without payment of further consideration. Each share of Preferred Stock will automatically convert into one share of Common Stock upon the closing of the Issuer's initial public offering.
HAREL INSURANCE COMPANY LTD. BY: /s/ Uri Rabinovitz, Vice President
2020-05-07
HAREL INSURANCE INVESTMENTS AND FINANCIAL SERVICES LTD. BY: /s/ Uri Rabinovitz, Vice President
2020-05-07